CoChat

Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease

Open access
Hall, Andrew M., Moore, Robert Y., Lopez, Oscar L., Kuller, Lewis, Becker, James T. · 2008 · Alzheimer's & Dementia
Cited by 112

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Background: Alzheimer's disease (AD) is the most common degenerative neurologic disorder. The onset of symptoms is insidious and follows a long period of progression of an asymptomatic pathology that proceeds in a precise anatomic and temporal sequence. Recent studies with quantitative magnetic resonance imaging techniques have shown the localization of the in vivo pathology of AD and its antecedent, mild cognitive impairment. The objective of the present study was to determine whether a sensitive and reliable marker for the presymptomatic phase of the disorder could be identified by longitudinal analysis of an initially asymptomatic, community‐based population. Methods: One hundred forty‐eight healthy, cognitively normal participants in the Cardiovascular Health Study–Cognition Study had detailed clinical examinations and magnetic resonance imaging scans in 1998–1999 and 2002–2003. Modulated voxel‐based morphometry was used to compare regional brain volumes in subjects who remained cognitively normal after 5 to 6 years of follow‐up (n = 127) with those who developed probable AD during the same period (n = 21). Results: Among normal subjects destined to develop AD, there was significant atrophy in the basal forebrain area as long as 4.5 years before the development of clinical symptoms. When the left hippocampus was also atrophic, the onset of dementia typically occurred earlier than in cases in which the atrophy was confined to basal forebrain. Conclusions: Atrophy in the basal forebrain precedes the development of AD in subjects with cognition judged to be normal by neuropsychological testing. The time required to develop dementia appears to be shortened if hippocampal atrophy is also present. These data indicate that atrophy restricted to medial basal forebrain is a biomarker that predicts development of probable AD in asymptomatic elderly subjects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2008.04.005

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 112

Metadata

Authors
Hall, A. M., Moore, R. Y., Lopez, O. L., Kuller, L., & Becker, J. T.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2008-07
Volume
4
Issue
4
Pages
271-279
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W1969694170
Cited by
112
References
16
FWCI
5.43
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.jalz.2008.04.005
The paper
Hall, A. M., Moore, R. Y., Lopez, O. L., Kuller, L., & Becker, J. T. (2008). Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2008.04.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.